-
Epidemiological Analysis of Colorectal Cancer in Cyprus Amidst the Absence of Organized Screening Programs Data From 2000 to 2020
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of the BCIS Conveyance Algorithm for Out-of-Hospital Cardiac Arrest Patients
Sep 9, 2025, 16:22 PM -
Examining the Opportunity Costs Due to Diabetic Macular Edema Taking Into Account Access Barriers Evaluated in the Barometer Program Survey in Colombia
Sep 9, 2025, 16:22 PM -
Characterization of a Large-Scale Real-World Data Source: Impact of Linking Closed Claims With Electronic Health Record Data
Sep 9, 2025, 16:22 PM -
Epidemiological Insights in Merkel Cell Carcinoma Across Europe: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Treatment Failure Event Categories Reveal Progressive Increases in Disease and Economic Burden Among Patients With Major Depressive Disorder
Sep 9, 2025, 16:22 PM -
Baseline Risk Heterogeneity in Cost-Effectiveness Analysis of the Diabetes Prevention Program
Sep 9, 2025, 16:22 PM -
Analysis of the Implementation of Additive PICOs in a European Joint Health Technology Assessment Implications of EUHTA for Pharma: A Qualitative Exploration
Sep 9, 2025, 16:22 PM -
A Case Study Demonstrating the Utility of the High-Tech Hub Electronic Prescribing Facility to Identify Off-Label Prescribing
Sep 9, 2025, 16:22 PM -
HTA Requirements for Medical Technologies in Germany
Sep 9, 2025, 16:22 PM -
Deep Real-World Analysis of Patients With Myelofibrosis Using Natural Language Processing and Machine Learning: A Methods Description
Sep 9, 2025, 16:22 PM -
MCDA Tool Adoption in Egypt: Room for Sustainability and Accessibility
Sep 9, 2025, 16:22 PM -
Evaluating the Role of Societal Perspectives in the EU Joint Clinical Assessment Framework and in EU-27 Health Technology Assessment Guidelines
Sep 9, 2025, 16:22 PM -
Prevalence of Post-Traumatic Stress Disorder Among Ambulance Officers During the COVID-19 Pandemic
Sep 9, 2025, 16:22 PM -
Healthcare Resource Use Among Children With Mucopolysaccharidosis Type III MPS III: A Retrospective Claims Database Analysis in the US
Sep 9, 2025, 16:22 PM -
(HCRU)/Costs and Epidemiology of Patients With ADHD in Germany: A Claims Data Study (HEDDA)
Sep 9, 2025, 16:22 PM -
Orphan Drugs Availability in Israel: A Base for Policy Development
Sep 9, 2025, 16:22 PM -
An Analysis of Possible Reference Countries for a US Most-Favored Nation Policy and the Associated Impact on the Global Pharmaceutical Industry
Sep 9, 2025, 16:22 PM -
Avacopan in the Treatment of ANCA-Associated Vasculitis: A Cost-Utility Analysis in Portugal
Sep 9, 2025, 16:22 PM -
Diverging Impacts of Evergreening and Biosimilars on Trastuzumab Utilization and Costs in South Korea: Implications for Sustainable Access and Market Competition
Sep 9, 2025, 16:22 PM
